June 17, 2025
New Framework Proposes Efficient Pathway to Advance Cell-Based Gene Therapies
A new framework developed in partnership with Friends of Cancer Research (Friends) and the Parker Institute for Cancer Immunotherapy was published in The Journal for ImmunoTherapy of Cancer, “Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials.” This pertinent collaborative manuscript emphasizes the need for flexible approaches to efficiently characterize and advance…
Read More